High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study
- 1 July 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 19 (4) , 385-391
- https://doi.org/10.1097/01.hco.0000126979.41946.7e
Abstract
The purpose of this review is to summarize the current understanding of the potentially antiatherogenic properties of high-density lipoprotein related to its different components. Recent findings on the role of the different high-density lipoprotein subspecies in reverse cholesterol transport, inflammation, endothelial dysfunction, and low-density lipoprotein oxidation are covered. Special emphasis is put on the heterogeneity of high-density lipoprotein and functional changes related to specific high-density lipoprotein particles with the potential therapeutic alterations of high-density lipoprotein metabolism. The diverse action of high-density lipoprotein observed could be explained by the heterogeneity of high-density lipoprotein particles with completely different composition and properties. The modification of specific high-density lipoprotein subpopulations to reach the maximum atheroprotective effects under various pathologic conditions bears great potential in lipid research.Keywords
This publication has 74 references indexed in Scilit:
- Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterolAmerican Heart Journal, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary EventsJAMA, 2001
- Physiological role and clinical relevance of high-density lipoprotein subclassesCurrent Opinion in Lipidology, 1994
- Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.Circulation, 1994
- Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activityBiochemistry, 1992
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1991
- Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoproteinBiochemistry, 1988
- Apolipoprotein A-I containing lipoproteins in coronary artery diseaseAtherosclerosis, 1987